FLO reports tomorrow — August 20 — and the stock carries one of the most heavily shorted profiles in its sector, with short interest running at 20.7% of the free float even as the price has spent the better part of 2026 falling.
The short position itself is the central tension this week. Bears have held a 20%-plus short interest for several months, and while the position has edged lower over the past month — down about 3.2% — the absolute level remains strikingly elevated for a packaged foods name. The official FINRA fortnightly report, settled July 31, counted 44 million shares short with a days-to-cover of 8.6 days. That figure implies any sustained covering could take nearly two weeks against normal trading volumes. Against that, the lending market looks genuinely relaxed: availability has tightened modestly over the week but remains at 127.9%, meaning more shares are available to borrow than are currently borrowed. Cost to borrow is just 0.53%, fractionally above its recent low but down sharply from the 0.84% level it touched in mid-July. The ORTEX short score — a composite of borrowing dynamics, short momentum, and positioning — has crept up to 72.7, its highest point in the ten-session window, confirming that the pressure is building quietly rather than dramatically. Options traders read as slightly more bullish than usual: the put/call ratio at 0.46 is marginally below its 20-day average of 0.47, and well within the year's range. Whatever hedging is happening is orderly.
The Street's stance on FLO has been a slow-motion downgrade cycle. Multiple analysts maintained ratings but cut targets heavily through the first half of 2026, with Deutsche Bank taking its target from $11 to $7 in March and Stephens from $11 to $8 in May. The consensus price target now stands at $8.80 against a current price of $7.38 — a modest 19% implied upside, though that figure reflects targets set before any August earnings catalyst. No rating changes from bellwether firms appear in the window since August 3. Factor scores reinforce the cautious picture: the short score rank sits in the bottom 3rd percentile of the universe, and the days-to-cover rank is in the 13th percentile. EPS momentum over both 30-day and 90-day horizons is weak — ranked 22nd and 30th percentile respectively — though the 12-month forward EPS year-on-year improvement ranks in the 71st percentile, suggesting analysts expect a recovery that the market hasn't yet priced in. The dividend score at 84th percentile remains a relative bright spot, but with the stock at $7.38 and dividend history data from 2022 stale, any yield math should be treated cautiously. Valuation by EV/EBITDA is 7.8x, up about 45 basis points over the past month — compression in price with stable enterprise value — and the price-to-earnings multiple has fallen from about 10.2x to 9.1x over the same window, reflecting the 13% slide in the stock's one-month price performance.
On the institutional side, BlackRock disclosed a notable build. Its most recent filing — dated July 31 — showed it added over 14.6 million shares, lifting its stake to 34.6 million shares or 16.3% of the company. That is a significant accumulation for a passive-adjacent holder and the largest single ownership move in the top-holder list. The CFO, Diego Scaglione, purchased 5,000 shares at $7.51 on June 8 — a modest open-market buy but notable given the CEO sold 209,000 shares at $8.03 on April 1, generating $1.68 million. Net insider activity over the rolling 90-day window shows a net positive share count, driven largely by director award grants rather than cash purchases, so the CFO's buy is the only unambiguous signal of conviction from the inside in recent months.
Past earnings prints have produced asymmetric results. Three of the four recent releases in the data drove moves of +2.9% to +11.1% the next day, with the exception being a small decline of 0.5%. Over five days, the picture was similarly positive, with three of four prints generating 6% to 9% gains. The one exception drifted 2.9% lower over the subsequent five sessions. That pattern may encourage short-side caution ahead of tomorrow's print, though the elevated short interest and low cost to borrow suggest the bears are not meaningfully retreating in anticipation.
With the print due after market close tomorrow, the number to watch is not just the top-line revenue trend — analyst sales estimates have been cut for multiple consecutive periods — but whether management provides any guidance that challenges or validates the bear case around acquisition integration drag and persistent margin pressure in wheat and vegetable oils.
See the live data behind this article on ORTEX.
Open FLO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
